A Brain Imaging Study to Assess the Binding of MSP-2020 to Serotonin 5-HT2A Receptors in Healthy Male Adults

NCT07329621 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Incomplete Response - Major Depressive Disorder (IR-MDD)

Interventions

DRUG: MSP-2020

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.